Cite
HARVARD Citation
Kim, H. et al. (2020). Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors. Pharmacology research & perspectives. 8 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, H. et al. (2020). Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors. Pharmacology research & perspectives. 8 (2), p. n/a. [Online].